Tania Marcourakis Selected Research

Clomipramine (Anafranil)

1/2015	Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment.
3/2006	Cognitive performance in depressed patients after chronic use of antidepressants.
9/2002	Memory performance in panic disorder patients after chronic use of clomipramine.
3/2002	Panic disorder patients have reduced cyclic AMP in platelets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tania Marcourakis Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 06/2005
3	Mental Disorders (Mental Disorder) 01/2020 - 03/2002
3	Inflammation (Inflammations) 05/2015 - 12/2003
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2020
2	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 02/2017
2	Sudden Infant Death (SID) 01/2021 - 03/2019
2	Neuroinflammatory Diseases 01/2021 - 05/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015 - 12/2008
2	Panic Disorder (Panic Attack) 09/2002 - 03/2002
1	COVID-19 05/2022
1	Zika Virus Infection 11/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2020
1	Neoplasms (Cancer) 10/2018
1	Body Weight (Weight, Body) 07/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2014
1	Lung Diseases (Lung Disease) 01/2013
1	Pneumonia (Pneumonitis) 01/2013
1	Acute Lung Injury 10/2012
1	Cognitive Dysfunction 01/2011
1	Agoraphobia 09/2002

Drug/Important Bio-Agent (IBA)

4	Clomipramine (Anafranil)FDA LinkGeneric 01/2015 - 03/2002
3	LipopolysaccharidesIBA 01/2021 - 10/2012
3	SmokeIBA 01/2021 - 02/2017
2	Hallucinogens (Psychedelics)IBA 05/2022 - 01/2022
2	EndocannabinoidsIBA 01/2020 - 03/2019
2	Environmental Pollutants (Pollutants, Environmental)IBA 10/2018 - 01/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2015 - 12/2008
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 01/2008
1	VaccinesIBA 05/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	MelatoninIBA 07/2017
1	Cocaine (Cocaine HCl)IBA 02/2017
1	anhydroecgonine methyl ester (methylecgonidine)IBA 02/2017
1	Crack CocaineIBA 02/2017
1	Cholinergic ReceptorsIBA 02/2017
1	Adenosine Triphosphatases (ATPase)IBA 05/2015
1	Glutamic Acid (Glutamate)FDA Link 05/2015
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Secretory Phospholipases A2IBA 03/2014
1	VenomsIBA 03/2014
1	Anacardic AcidsIBA 01/2013
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2013
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2013
1	AntioxidantsIBA 01/2011
1	Apolipoproteins E (ApoE)IBA 12/2008
1	ApolipoproteinsIBA 12/2008
1	Oxygen (Dioxygen)IBA 01/2008
1	Fluoxetine (Prozac)FDA LinkGeneric 03/2006
1	Sertraline (Zoloft)FDA LinkGeneric 03/2006
1	Imipramine (Janimine)FDA LinkGeneric 03/2006
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2005
1	AnionsIBA 06/2005
1	NF-kappa B (NF-kB)IBA 12/2003
1	Cyclic GMPIBA 03/2002
1	Cyclic AMP (AMP, Cyclic)IBA 03/2002